-
EMA accepts regulatory submission for Takeda’s dengue vaccine candidate
europeanpharmaceuticalreview
March 29, 2021
The submission is the first in a series that will include dengue-endemic countries, it includes long-term Phase III safety and efficacy data for the TAK-003 vaccine candidate.
-
Researchers Alter Mosquitoes to Resist Dengue Infection
drugs
January 17, 2020
Mosquitoes that can't be infected by or spread dengue virus have been created by scientists. The researchers genetically engineered the mosquitoes to be resistant to all four types of dengue, a mosquito-borne virus that's a significant global health threa
-
Dengue virus becoming resistant to vaccines and therapeutics due to mutations in specific protein
worldpharmanews
September 23, 2019
Researchers from Duke-NUS Medical School (DukeNUS), in collaboration with the Agency for Science, Technology and Research (A*STAR)'s Bioinformatics Institute (BII) ...
-
Philippines may re-introduce controversial dengue vaccine
europeanpharmaceuticalreview
August 08, 2019
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
-
FDA Approves Dengvaxia
drugs
May 06, 2019
FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions.
-
FDA Approves Dengvaxia
drugs
May 06, 2019
FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions.
-
Dengvaxia approved for dengue in EU
pharmatimes
December 21, 2018
Dengvaxia will be available in Europe for individuals 9-45 years of age with a documented prior dengue infection, and who are living in endemic areas.
-
ADVA calls for collaboration efforts to tackle dengue threat
biospectrumasia
July 09, 2018
Asian Dengue Vaccination Advocacy (ADVA), a scientific working group is staging the 3rd Asia Dengue Summit from 5-6 July 2018 in partnership with Malaysia’s Ministry of Health...
-
Philippines' Department of Health demands full refund of $70m Dengvaxia programme from Sanofi
pharmafile
January 31, 2018
In the latest update of the Sanofi Philippines dengue vaccine scandal, the U.S. Department of Health demanded that French pharmaceutical companies pay a full refund of the three billion Philippine pesos paid by the Philippine government to immunize its ci
-
Mother’s antibodies may worsen dengue infection in children
biospectrumasia
January 29, 2018
A dengue vaccine that stimulates a strong T cell response in babies has been found to provide better and broader protection than vaccines which induce the production of mainly antibodies.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
